{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:20:06Z","timestamp":1770888006005,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Subependymal giant cell astrocytoma (SEGA) is occasionally seen in tuberous sclerosis complex (TSC). Two main options are currently available for treating SEGA: surgical resection or pharmacotherapy using mammalian target of rapamycin inhibitors (mTORi). We hypothesized that opportunities for surgical resection of SEGA would have reduced with the advent of mTORi.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively reviewed the charts of patients treated between August 1979 and July 2020, divided into a pre-mTORi era group (Pre-group) of patients treated before November 2012, and a post-mTORi era group (Post-group) comprising patients treated from November 2012, when mTORi became available in Japan for SEGA. We compared groups in terms of treatment with surgery or mTORi. We also reviewed SEGA size, rate of acute hydrocephalus, recurrence of SEGA, malignant transformation and adverse effects of mTORi.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 120 patients with TSC visited our facility, including 24 patients with SEGA. Surgical resection was significantly more frequent in the Pre-group (6 of 7 patients, 86\u2009%) than in the Post-group (2 of 17 patients, 12\u2009%; <jats:italic>p<\/jats:italic>\u2009=\u20090.001). Acute hydrocephalus was seen in 1 patient (4\u2009%), and no patients showed malignant transformation of SEGA. The group treated using mTORi showed significantly smaller SEGA compared with the group treated under a wait-and-see policy (<jats:italic>p<\/jats:italic>\u2009=\u20090.012). Adverse effects of pharmacotherapy were identified in seven (64\u2009%; 6 oral ulcers, 1 irregular menstruation) of the 11 patients receiving mTORi.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The Post-group underwent surgery significantly less often than the Pre-group. Since the treatment option to use mTORi in the treatment of SEGA in TSC became available, opportunities for surgical resection have decreased in our facility.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-021-02160-5","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T02:02:15Z","timestamp":1617156135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility"],"prefix":"10.1186","volume":"21","author":[{"given":"Kyoichi","family":"Tomoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5308-2965","authenticated-orcid":false,"given":"Ayataka","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikanori","family":"Inenaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Okanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Ogai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keishiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Obana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Masui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Enoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,31]]},"reference":[{"key":"2160_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-020-04705-4","author":"C Russo","year":"2020","unstructured":"Russo C, Nastro A, Cicala D, De Liso M, Covelli EM, Cinalli G. Neuroimaging in tuberous sclerosis complex. Childs Nerv Syst. 2020. https:\/\/doi.org\/10.1007\/s00381-020-04705-4.","journal-title":"Childs Nerv Syst"},{"key":"2160_CR2","doi-asserted-by":"publisher","first-page":"e63910","DOI":"10.1371\/journal.pone.0063910","volume":"8","author":"M Wataya-Kaneda","year":"2013","unstructured":"Wataya-Kaneda M, Tanaka M, Hamasaki T, Katayama I. Trends in the prevalence of tuberous sclerosis complex manifestations: an epidemiological study of 166 Japanese patients. PloS one. 2013;8:e63910. https:\/\/doi.org\/10.1371\/journal.pone.0063910.","journal-title":"PloS one"},{"key":"2160_CR3","doi-asserted-by":"publisher","first-page":"16747","DOI":"10.1038\/s41598-018-35168-y","volume":"8","author":"A Fujimoto","year":"2018","unstructured":"Fujimoto A, Okanishi T, Imai S, Ogai M, Fukunaga A, Nakamura H, Sato K, Obana A, Masui T, Arai Y, Enoki H. Establishment of a regional interdisciplinary medical system for managing patients with tuberous sclerosis complex (TSC). Sci Rep. 2018;8:16747. https:\/\/doi.org\/10.1038\/s41598-018-35168-y.","journal-title":"Sci Rep"},{"key":"2160_CR4","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3389\/fneur.2019.00821","volume":"10","author":"AC Jansen","year":"2019","unstructured":"Jansen AC, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, D\u2019Amato L, Beaure d\u2019Aug\u00e8res G, de Vries PJ, Ferreira JC, Feucht M, Fladrowski C, Hertzberg C, Jozwiak S, Lawson JA, Macaya A, Marques R, Nabbout R, O\u2019Callaghan F, Qin J, Sander V, Sauter M, Shah S, Takahashi Y, Touraine R, Youroukos S, Zonnenberg B, Kingswood JC. Newly diagnosed and growing subependymal giant cell astrocytoma in adults with tuberous sclerosis complex: results from the international TOSCA study. Front Neurol. 2019;10:821. https:\/\/doi.org\/10.3389\/fneur.2019.00821.","journal-title":"Front Neurol"},{"key":"2160_CR5","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3389\/fneur.2019.00705","volume":"10","author":"AC Jansen","year":"2019","unstructured":"Jansen AC, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, Dahlin M, D\u2019Amato L, d\u2019Aug\u00e8res GB, de Vries PJ, Ferreira JC, Feucht M, Fladrowski C, Hertzberg C, Jozwiak S, Lawson JA, Macaya A, Marques R, Nabbout R, O\u2019Callaghan F, Qin J, Sander V, Sauter M, Shah S, Takahashi Y, Touraine R, Youroukos S, Zonnenberg B, Kingswood JC. Clinical characteristics of subependymal giant cell astrocytoma in tuberous sclerosis complex. Front Neurol. 2019;10:705. https:\/\/doi.org\/10.3389\/fneur.2019.00705.","journal-title":"Front Neurol"},{"key":"2160_CR6","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s40265-016-0552-9","volume":"76","author":"P Curatolo","year":"2016","unstructured":"Curatolo P, Bj\u00f8rnvold M, Dill PE, Ferreira JC, Feucht M, Hertzberg C, Jansen A, J\u00f3\u017awiak S, Kingswood JC, Kotulska K, Macaya A, Moavero R, Nabbout R, Zonnenberg BA. The role of mTOR inhibitors in the treatment of patients with tuberous sclerosis complex: evidence-based and expert opinions. Drugs. 2016;76:551\u201365. https:\/\/doi.org\/10.1007\/s40265-016-0552-9.","journal-title":"Drugs"},{"key":"2160_CR7","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/s1470-2045(14)70489-9","volume":"15","author":"DN Franz","year":"2014","unstructured":"Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, Witt O, Kohrman MH, Flamini JR, Wu JY, Curatolo P, de Vries PJ, Berkowitz N, Anak O, Niolat J, Jozwiak S. Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study. Lancet Oncol. 2014;15:1513\u201320. https:\/\/doi.org\/10.1016\/s1470-2045(14)70489-9.","journal-title":"Lancet Oncol"},{"key":"2160_CR8","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s00381-018-3826-6","volume":"34","author":"M Fohlen","year":"2018","unstructured":"Fohlen M, Ferrand-Sorbets S, Delalande O, Dorfm\u00fcller G. Surgery for subependymal giant cell astrocytomas in children with tuberous sclerosis complex. Childs Nerv Syst. 2018;34:1511\u20139. https:\/\/doi.org\/10.1007\/s00381-018-3826-6.","journal-title":"Childs Nerv Syst"},{"key":"2160_CR9","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00381-019-04449-w","volume":"36","author":"F Giordano","year":"2020","unstructured":"Giordano F, Moscheo C, Lenge M, Biagiotti R, Mari F, Sardi I, Buccoliero AM, Mongardi L, Aronica E, Guerrini R, Genitori L. Neurosurgical treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex: a series of 44 surgical procedures in 31 patients. Childs Nerv Syst. 2020;36:951\u201360. https:\/\/doi.org\/10.1007\/s00381-019-04449-w.","journal-title":"Childs Nerv Syst"},{"key":"2160_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ajmg.c.31647","volume":"178","author":"DS Lu","year":"2018","unstructured":"Lu DS, Karas PJ, Krueger DA, Weiner HL. Central nervous system manifestations of tuberous sclerosis complex. Am J Med Genet C Semin Med Genet. 2018;178:291\u20138. https:\/\/doi.org\/10.1002\/ajmg.c.31647.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"2160_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1515\/revneuro-2017-0027","volume":"29","author":"DL Chan","year":"2018","unstructured":"Chan DL, Calder T, Lawson JA, Mowat D, Kennedy SE. The natural history of subependymal giant cell astrocytomas in tuberous sclerosis complex: a review. Rev Neurosci. 2018;29:295\u2013301. https:\/\/doi.org\/10.1515\/revneuro-2017-0027.","journal-title":"Rev Neurosci"},{"key":"2160_CR12","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00381-014-2383-x","volume":"30","author":"T Ouyang","year":"2014","unstructured":"Ouyang T, Zhang N, Benjamin T, Wang L, Jiao J, Zhao Y, Chen J. Subependymal giant cell astrocytoma: current concepts, management, and future directions. Childs Nerv Syst. 2014;30:561\u201370. https:\/\/doi.org\/10.1007\/s00381-014-2383-x.","journal-title":"Childs Nerv Syst"},{"key":"2160_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-020-04638-y","author":"VR Desai","year":"2020","unstructured":"Desai VR, Jenson AV, Hoverson E, Desai RM, Boghani Z, Lee MR. Stereotactic laser ablation for subependymal giant cell astrocytomas: personal experience and review of the literature. Childs Nerv Syst. 2020. https:\/\/doi.org\/10.1007\/s00381-020-04638-y.","journal-title":"Childs Nerv Syst"},{"key":"2160_CR14","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.3171\/2019.10.Focus19746","volume":"48","author":"AH Feroze","year":"2020","unstructured":"Feroze AH, McGrath M, Williams JR, Young CC, Ene CI, Buckley RT, Cole BL, Ojemann JG, Hauptman JS. Laser interstitial thermal therapy for pediatric atypical teratoid\/rhabdoid tumor: case report. Neurosurg Focus. 2020;48:E11. https:\/\/doi.org\/10.3171\/2019.10.Focus19746.","journal-title":"Neurosurg Focus"},{"key":"2160_CR15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3171\/2016.10.Peds16352","volume":"19","author":"G Cinalli","year":"2017","unstructured":"Cinalli G, Imperato A, Mirone G, Di Martino G, Nicosia G, Ruggiero C, Aliberti F, Spennato P. Initial experience with endoscopic ultrasonic aspirator in purely neuroendoscopic removal of intraventricular tumors. J Neurosurg Pediatr. 2017;19:325\u201332. https:\/\/doi.org\/10.3171\/2016.10.Peds16352.","journal-title":"J Neurosurg Pediatr"},{"key":"2160_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3171\/2013.9.Peds13193","volume":"13","author":"DH Harter","year":"2014","unstructured":"Harter DH, Bassani L, Rodgers SD, Roth J, Devinsky O, Carlson C, Wisoff JH, Weiner HL. A management strategy for intraventricular subependymal giant cell astrocytomas in tuberous sclerosis complex. J Neurosurg Pediatr. 2014;13:21\u20138. https:\/\/doi.org\/10.3171\/2013.9.Peds13193.","journal-title":"J Neurosurg Pediatr"},{"key":"2160_CR17","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.wneu.2015.11.052","volume":"87","author":"ET Hidalgo","year":"2016","unstructured":"Hidalgo ET, Ali A, Weiner HL, Harter DH. Resection of intraventricular tumors in children by purely endoscopic means. World Neurosurg. 2016;87:372\u201380. https:\/\/doi.org\/10.1016\/j.wneu.2015.11.052.","journal-title":"World Neurosurg"},{"key":"2160_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3171\/2011.12.Peds11349","volume":"9","author":"SD Rodgers","year":"2012","unstructured":"Rodgers SD, Bassani L, Weiner HL, Harter DH. Stereotactic endoscopic resection and surgical management of a subependymal giant cell astrocytoma: case report. J Neurosurg Pediatr. 2012;9:417\u201320. https:\/\/doi.org\/10.3171\/2011.12.Peds11349.","journal-title":"J Neurosurg Pediatr"},{"key":"2160_CR19","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.1016\/j.wneu.2019.10.099","volume":"134","author":"RG Tawk","year":"2020","unstructured":"Tawk RG, Akinduro OO, Grewal SS, Brasiliense L, Grand W, Grotenhuis A. Endoscopic transforaminal transchoroidal approach to the third ventricle for cystic and solid tumors. World Neurosurg. 2020;134:e453-9. https:\/\/doi.org\/10.1016\/j.wneu.2019.10.099.","journal-title":"World Neurosurg"},{"key":"2160_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13023-019-1072-y","volume":"14","author":"S Auvin","year":"2019","unstructured":"Auvin S, Bissler JJ, Cottin V, Fujimoto A, Hofbauer GFL, Jansen AC, J\u00f3\u017awiak S, Kerecuk L, Kingswood JC, Moavero R, Torra R, Villanueva V. A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report. Orphanet J Rare Dis. 2019;14:91. https:\/\/doi.org\/10.1186\/s13023-019-1072-y.","journal-title":"Orphanet J Rare Dis"},{"key":"2160_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.pediatrneurol.2019.06.018","volume":"102","author":"D Alsowat","year":"2020","unstructured":"Alsowat D, Zak M, McCoy B, Kabir N, Al-Mehmadi S, Chan V, Whitney R. A review of investigations for patients with tuberous sclerosis complex who were referred to the tuberous sclerosis clinic at the hospital for sick children: identifying gaps in surveillance. Pediatr Neurol. 2020;102:44\u20138. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2019.06.018.","journal-title":"Pediatr Neurol"},{"key":"2160_CR22","doi-asserted-by":"publisher","first-page":"e0158476","DOI":"10.1371\/journal.pone.0158476","volume":"11","author":"DN Franz","year":"2016","unstructured":"Franz DN, Belousova E, Sparagana S, Bebin EM, Frost MD, Kuperman R, Witt O, Kohrman MH, Flamini JR, Wu JY, Curatolo P, de Vries PJ, Berkowitz N, Niolat J, J\u00f3\u017awiak S. Long-term use of everolimus in patients with tuberous sclerosis complex: final results from the EXIST-1 study. PloS one. 2016;11:e0158476. https:\/\/doi.org\/10.1371\/journal.pone.0158476.","journal-title":"PloS one"},{"key":"2160_CR23","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/ndt\/gfu013","volume":"29","author":"JC Kingswood","year":"2014","unstructured":"Kingswood JC, Jozwiak S, Belousova ED, Frost MD, Kuperman RA, Bebin EM, Korf BR, Flamini JR, Kohrman MH, Sparagana SP, Wu JY, Brechenmacher T, Stein K, Berkowitz N, Bissler JJ, Franz DN. The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1. Nephrol Dial Transplant. 2014;29:1203\u201310. https:\/\/doi.org\/10.1093\/ndt\/gfu013.","journal-title":"Nephrol Dial Transplant"},{"key":"2160_CR24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1212\/cpj.0000000000000514","volume":"8","author":"DN Franz","year":"2018","unstructured":"Franz DN, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, Curatolo P, de Vries PJ, Dlugos DJ, Voi M, Fan J, Vaury A, Pelov D, French JA. Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial. Neurol Clin Pract. 2018;8:412\u201320. https:\/\/doi.org\/10.1212\/cpj.0000000000000514.","journal-title":"Neurol Clin Pract"},{"key":"2160_CR25","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s11940-013-0249-2","volume":"15","author":"DA Krueger","year":"2013","unstructured":"Krueger DA. Management of CNS-related disease manifestations in patients with tuberous sclerosis complex. Curr Treat Options Neurol. 2013;15:618\u201333. https:\/\/doi.org\/10.1007\/s11940-013-0249-2.","journal-title":"Curr Treat Options Neurol"},{"key":"2160_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.12703\/p6-116","volume":"6","author":"AM Taveira-DaSilva","year":"2014","unstructured":"Taveira-DaSilva AM, Moss J. Management of lymphangioleiomyomatosis. F1000 Prime Rep. 2014;6:116. https:\/\/doi.org\/10.12703\/p6-116.","journal-title":"F1000 Prime Rep"},{"key":"2160_CR27","doi-asserted-by":"publisher","first-page":"14698","DOI":"10.1038\/s41598-018-32795-3","volume":"8","author":"N Chebib","year":"2018","unstructured":"Chebib N, Archer F, Bobet-Erny A, Leroux C, Cottin V. Dysregulation of the endothelin pathway in lymphangioleiomyomatosis with no direct effect on cell proliferation and migration. Sci Rep. 2018;8:14698. https:\/\/doi.org\/10.1038\/s41598-018-32795-3.","journal-title":"Sci Rep"},{"key":"2160_CR28","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.ejpn.2018.06.007","volume":"22","author":"DA Krueger","year":"2018","unstructured":"Krueger DA, Capal JK, Curatolo P, Devinsky O, Ess K, Tzadok M, Koenig MK, Narayanan V, Ramos F, Jozwiak S, de Vries P, Jansen AC, Wong M, Mowat D, Lawson J, Bruns S, Franz DN. Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience. Eur J Paediatr Neurol. 2018;22:1066\u201373. https:\/\/doi.org\/10.1016\/j.ejpn.2018.06.007.","journal-title":"Eur J Paediatr Neurol"},{"key":"2160_CR29","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s11060-020-03487-8","volume":"147","author":"DR Weidman","year":"2020","unstructured":"Weidman DR, Palasamudram S, Zak M, Whitney R, McCoy B, Bouffet E, Taylor M, Shroff M, Bartels U. The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA). J Neurooncol. 2020;147:731\u20136. https:\/\/doi.org\/10.1007\/s11060-020-03487-8.","journal-title":"J Neurooncol"},{"key":"2160_CR30","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1177\/088307389801301206.","volume":"13","author":"ES Roach","year":"1998","unstructured":"Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol. 1998;13:624\u20138. https:\/\/doi.org\/10.1177\/088307389801301206.","journal-title":"J Child Neurol."},{"key":"2160_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.0012013.08.001","volume":"49","author":"H Northrup","year":"2013","unstructured":"Northrup H, Krueger DA, Northrup H, Krueger DA, Roberds S, Smith K, Sampson J, Korf B, Kwiatkowski DJ, Mowat D, Nellist M, Northrup H, Povey S, de Vries P, Byars A, Dunn D, Ess K, Hook D, Jansen A, King B, Sahin M, Whittemore V, Thiele E, Bebin EM, Chugani HT, Crino P, Curatolo P, Holmes G, Nabbout R, O\u2019Callaghan F, Wheless J, Wu J, Darling TN, Cowen EW, Gosnell E, Hebert A, Mlynarczyk G, Soltani K, Teng J, Wataya-Kaneda M, Witman PM, Kingswood C, Bissler J, Budde K, Hulbert J, Guay-Woodford L, Sampson J, Sauter M, Zonneberg B, J\u00f3\u017awiak S, Bartels U, Berhouma M, Franz DN, Koenig MK, Krueger DA, Roach ES, Roth J, Wang H, Weiner H, McCormack FX, Almoosa K, Brody A, Burger C, Cottin V, Finlay G, Glass J, Henske EP, Johnson S, Kotloff R, Lynch D, Moss J, Smith K, Rhu J, Da Silva AT, Young LR, Knilans T, Hinton R, Prakash A, Romp R, Singh AD, DebRoy A, Chen P-L, Sparagana S, Frost MD. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013;49:243\u201354. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2013.08.0012013.08.001.","journal-title":"Pediatr Neurol."},{"key":"2160_CR32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.0022013.08.002","volume":"49","author":"DA Krueger","year":"2013","unstructured":"Krueger DA, Northrup H, Northrup H, Krueger DA, Roberds S, Smith K, Sampson J, Korf B, Kwiatkowski DJ, Mowat D, Nellist M, Northrup H, Povey S, de Vries P, Byars A, Dunn D, Ess K, Hook D, Jansen A, King B, Sahin M, Whittemore V, Thiele E, Bebin EM, Chugani HT, Crino P, Curatolo P, Holmes G, Nabbout R, O\u2019Callaghan F, Wheless J, Wu J, Darling TN, Cowen EW, Gosnell E, Hebert A, Mlynarczyk G, Soltani K, Teng J, Wataya-Kaneda M, Witman PM, Kingswood C, Bissler J, Budde K, Hulbert J, Guay-Woodford L, Sampson J, Sauter M, Zonneberg B, J\u00f3\u017awiak S, Bartels U, Berhouma M, Franz DN, Koenig MK, Krueger DA, Roach ES, Roth J, Wang H, Weiner H, McCormack FX, Almoosa K, Brody A, Burger C, Cottin V, Finlay G, Glass J, Henske EP, Johnson S, Kotloff R, Lynch D, Moss J, Smith K, Rhu J, Da Silva AT, Young LR, Knilans T, Hinton R, Prakash A, Romp R, Singh AD, DebRoy A, Chen P-L, Sparagana S, Frost MD. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013;49:255\u201365. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2013.08.0022013.08.002.","journal-title":"Pediatr Neurol."},{"key":"2160_CR33","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1136\/jnnp.66.3.370","volume":"66","author":"R Nabbout","year":"1999","unstructured":"Nabbout R, Santos M, Rolland Y, Delalande O, Dulac O, Chiron C. Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis. J Neurol Neurosurg Psychiatry. 1999;66:370\u20135. https:\/\/doi.org\/10.1136\/jnnp.66.3.370.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2160_CR34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.pediatrneurol.2013.08.0172013.08.017","volume":"49","author":"J Roth","year":"2013","unstructured":"Roth J, Roach ES, Bartels U, J\u00f3\u017awiak S, Koenig MK, Weiner HL, Franz DN, Wang HZ. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment recommendations from the international tuberous sclerosis complex consensus conference 2012. Pediatr Neurol. 2013;49:439\u201344. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2013.08.0172013.08.017.","journal-title":"Pediatr Neurol."},{"key":"2160_CR35","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.spen.2015.10.003","volume":"22","author":"S J\u00f3\u017awiak","year":"2015","unstructured":"J\u00f3\u017awiak S, Mandera M, M\u0142ynarski W. Natural history and current treatment options for subependymal giant cell astrocytoma in tuberous sclerosis complex. Semin Pediatr Neurol. 2015;22:274\u201381. https:\/\/doi.org\/10.1016\/j.spen.2015.10.003.","journal-title":"Semin Pediatr Neurol"},{"key":"2160_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.pediatrneurol.2016.11.003","volume":"68","author":"R Moavero","year":"2017","unstructured":"Moavero R, Carai A, Mastronuzzi A, Marciano S, Graziola F, Vigevano F, Curatolo P. Everolimus alleviates obstructive hydrocephalus due to subependymal giant cell astrocytomas. Pediatr Neurol. 2017;68:59\u201363. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2016.11.003.","journal-title":"Pediatr Neurol"},{"key":"2160_CR37","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.pneurobio.2011.05.005","volume":"94","author":"D Ore\u0161kovi\u0107","year":"2011","unstructured":"Ore\u0161kovi\u0107 D, Klarica M. Development of hydrocephalus and classical hypothesis of cerebrospinal fluid hydrodynamics: facts and illusions. Prog Neurobiol. 2011;94:238\u201358. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.05.005.","journal-title":"Prog Neurobiol"},{"key":"2160_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2017.04.008","author":"MS Arroyo","year":"2017","unstructured":"Arroyo MS, Krueger DA, Broomall E, Stevenson CB, Franz DN. Acute management of symptomatic subependymal giant cell astrocytoma with everolimus. Pediatr Neurol. 2017. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2017.04.008.","journal-title":"Pediatr Neurol"},{"key":"2160_CR39","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jocn.2003.12.016","volume":"11","author":"A Fujimoto","year":"2004","unstructured":"Fujimoto A, Matsumura A, Maruno T, Yasuda S, Yamamoto M, Nose T. Normal pressure hydrocephalus after gamma knife radiosurgery for cerebellopontine angle meningioma. J Clin Neurosci. 2004;11:785\u20137. https:\/\/doi.org\/10.1016\/j.jocn.2003.12.016.","journal-title":"J Clin Neurosci"},{"key":"2160_CR40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.neuroscience.2018.09.029","volume":"392","author":"D Ore\u0161kovi\u0107","year":"2018","unstructured":"Ore\u0161kovi\u0107 D, Marakovi\u0107 J, Varda R, Rado\u0161 M, Jurjevi\u0107 I, Klarica M. New insight into the mechanism of mannitol effects on cerebrospinal fluid pressure decrease and craniospinal fluid redistribution. Neuroscience. 2018;392:164\u201371. https:\/\/doi.org\/10.1016\/j.neuroscience.2018.09.029.","journal-title":"Neuroscience"},{"key":"2160_CR41","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s00381-002-0700-2","volume":"19","author":"V Cuccia","year":"2003","unstructured":"Cuccia V, Zuccaro G, Sosa F, Monges J, Lubienieky F, Taratuto AL. Subependymal giant cell astrocytoma in children with tuberous sclerosis. Childs Nerv Syst. 2003;19:232\u201343. https:\/\/doi.org\/10.1007\/s00381-002-0700-2.","journal-title":"Childs Nerv Syst"},{"key":"2160_CR42","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3171\/2010.9.Jns10816","volume":"114","author":"KJ Park","year":"2011","unstructured":"Park KJ, Kano H, Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD. Gamma Knife surgery for subependymal giant cell astrocytomas. Clinical article. J Neurosurg. 2011;114:808\u201313. https:\/\/doi.org\/10.3171\/2010.9.Jns10816.","journal-title":"J Neurosurg"},{"key":"2160_CR43","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1468-1331.2009.02567.x","volume":"16","author":"ME Adriaensen","year":"2009","unstructured":"Adriaensen ME, Schaefer-Prokop CM, Stijnen T, Duyndam DA, Zonnenberg BA, Prokop M. Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature. Eur J Neurol. 2009;16:691\u20136. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02567.x.","journal-title":"Eur J Neurol"},{"key":"2160_CR44","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1007\/s00381-014-2555-8","volume":"30","author":"K Kotulska","year":"2014","unstructured":"Kotulska K, Borkowska J, Mandera M, Roszkowski M, Jurkiewicz E, Grajkowska W, Bilska M, J\u00f3\u017awiak S. Congenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex. Childs Nerv Syst. 2014;30:2037\u201342. https:\/\/doi.org\/10.1007\/s00381-014-2555-8.","journal-title":"Childs Nerv Syst"},{"key":"2160_CR45","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.spen.2015.10.006","volume":"22","author":"R Moavero","year":"2015","unstructured":"Moavero R, Romagnoli G, Graziola F, Curatolo P. Mammalian target of rapamycin inhibitors and life-threatening conditions in tuberous sclerosis complex. Semin Pediatr Neurol. 2015;22:282\u201394. https:\/\/doi.org\/10.1016\/j.spen.2015.10.006.","journal-title":"Semin Pediatr Neurol"},{"key":"2160_CR46","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1185\/03007995.2012.658907","volume":"28","author":"P Sun","year":"2012","unstructured":"Sun P, Kohrman M, Liu J, Guo A, Rogerio J, Krueger D. Outcomes of resecting subependymal giant cell astrocytoma (SEGA) among patients with SEGA-related tuberous sclerosis complex: a national claims database analysis. Curr Med Res Opin. 2012;28:657\u201363. https:\/\/doi.org\/10.1185\/03007995.2012.658907.","journal-title":"Curr Med Res Opin"},{"key":"2160_CR47","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1185\/03007995.2012.7198652012.719865","volume":"28","author":"M Berhouma","year":"2012","unstructured":"Berhouma M, Dubourg J, Messerer M. 2012 Neurology: Letter to the editor. Re: Sun P, Kohrman M, Liu J, et al. Outcomes of resecting subependymal giant cell astrocytoma (SEGA) among patients with SEGA-related tuberous sclerosis complex: a national claims database analysis. Curr Med Res Opin. 2012;28:657\u201363. https:\/\/doi.org\/10.1185\/03007995.2012.7198652012.719865 Current medical research and opinion 28: 1571\u20131572; author reply 1572\u20131573.","journal-title":"Curr Med Res Opin."},{"key":"2160_CR48","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13023-019-1012-x","volume":"14","author":"M Li","year":"2019","unstructured":"Li M, Zhou Y, Chen C, Yang T, Zhou S, Chen S, Wu Y, Cui Y. Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: a meta-analysis. Orphanet J Rare Dis. 2019;14:39. https:\/\/doi.org\/10.1186\/s13023-019-1012-x.","journal-title":"Orphanet J Rare Dis"},{"key":"2160_CR49","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ejpn.2012.12.008","volume":"17","author":"S J\u00f3\u017awiak","year":"2013","unstructured":"J\u00f3\u017awiak S, Nabbout R, Curatolo P. Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations. Eur J Paediatr Neurol. 2013;17:348\u201352. https:\/\/doi.org\/10.1016\/j.ejpn.2012.12.008.","journal-title":"Eur J Paediatr Neurol"},{"key":"2160_CR50","first-page":"181","volume":"35","author":"A Taraszewska","year":"1997","unstructured":"Taraszewska A, Kroh H, Majchrowski A. Subependymal giant cell astrocytoma: clinical, histologic and immunohistochemical characteristic of 3 cases. Folia Neuropathol. 1997;35:181\u20136.","journal-title":"Folia Neuropathol"},{"key":"2160_CR51","first-page":"39","volume":"49","author":"W Grajkowska","year":"2011","unstructured":"Grajkowska W, Kotulska K, Jurkiewicz E, Roszkowski M, Daszkiewicz P, J\u00f3\u017awiak S, Matyja E. Subependymal giant cell astrocytomas with atypical histological features mimicking malignant gliomas. Folia Neuropathol. 2011;49:39\u201346.","journal-title":"Folia Neuropathol"},{"key":"2160_CR52","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/jnen\/nlaa040","volume":"79","author":"A Bongaarts","year":"2020","unstructured":"Bongaarts A, de Jong JM, Broekaart DWM, van Scheppingen J, Anink JJ, Mijnsbergen C, Jansen FE, Spliet WGM, den Dunnen WFA, Gruber VE, Scholl T, Hainfellner JA, Feucht M, Borkowska J, Kotulska K, Jozwiak S, Grajkowska W, Buccoliero AM, Caporalini C, Giordano F, Genitori L, Scicluna BP, -van SchoutenMeeteren AYN, van Vliet EA, M\u00fchlebner A, Mills JD, Aronica E. Dysregulation of the MMP\/TIMP proteolytic system in subependymal giant cell astrocytomas in patients with tuberous sclerosis complex: modulation of MMP by MicroRNA-320d in vitro. J Neuropathol Exp Neurol. 2020;79:777\u201390. https:\/\/doi.org\/10.1093\/jnen\/nlaa040.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2160_CR53","doi-asserted-by":"publisher","first-page":"746","DOI":"10.4103\/ajns.AJNS_231_16","volume":"12","author":"E Kasper","year":"2017","unstructured":"Kasper E, Laviv Y, Sebai ME, Lin N, Butler W. Subependymal giant cell astrocytoma: associated hyperproteinorrhachia causing shunt failures and nonobstructive hydrocephalus - report of successful treatment with long-term follow-up. Asian J Neurosurg. 2017;12:746\u201350. https:\/\/doi.org\/10.4103\/ajns.AJNS_231_16.","journal-title":"Asian J Neurosurg"},{"key":"2160_CR54","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00701-014-2309-0","volume":"157","author":"Y Laviv","year":"2015","unstructured":"Laviv Y, Jackson S, Rappaport ZH. Persistent communicating hydrocephalus in adult tuberous sclerosis patients: a possible therapeutic role for everolimus. Acta Neurochir (Wien). 2015;157:241\u20135. https:\/\/doi.org\/10.1007\/s00701-014-2309-0.","journal-title":"Acta Neurochir (Wien)"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02160-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-021-02160-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02160-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T02:02:27Z","timestamp":1617156147000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-021-02160-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,31]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2160"],"URL":"https:\/\/doi.org\/10.1186\/s12883-021-02160-5","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,31]]},"assertion":[{"value":"1 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee at Seirei Hamamatsu General Hospital approved the protocol for this study (approval no. 3390), which was performed in accordance with the principles of the Declaration of Helsinki.All patients, or the parents of pediatric patients, provided written informed consent for the publication of case details.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval, and consent to participate"}},{"value":"Written consent for publication was obtained from all patients and\/or parents of the patients in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"139"}}